Drug Development Doesn’t Always Have to Start From Scratch

Article   Jun 05, 2017 | Simon Pearce, Market Segment Manager for Organics, with Thermo Fisher Scientific

 
Drug Development Doesn’t Always Have to Start From Scratch
 
 
 

RELATED ARTICLES

Key Challenges and Pain Points in the Global Laboratory Market

Article

To better understand the key challenges and pain points in the global laboratory market, Agilent commissioned Frost & Sullivan to carry out an independent survey of 700 scientists across the laboratory employee spectrum. Here we highlight a selection of the survey’s key findings.

READ MORE

Industrializing Proteomics to Transform the Future of Healthcare

Article

With very few biomarkers having made it into clinical practice, we find out how some proteomics laboratories are using a factory-type set up to get more biomarkers into the clinic, faster.

READ MORE

Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article

New diagnostic tool could therefore lead to improved therapeutic success and a better quality of life for the millions of patients suffering from Sjögren’s syndrome around the world.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE